Targeting glutamine metabolism as a therapeutic strategy for cancer

J Jin, JK Byun, YK Choi, KG Park - Experimental & Molecular Medicine, 2023 - nature.com
Proliferating cancer cells rely largely on glutamine for survival and proliferation. Glutamine
serves as a carbon source for the synthesis of lipids and metabolites via the TCA cycle, as …

Overcoming cancer chemotherapy resistance by the induction of ferroptosis

Y Wang, X Wu, Z Ren, Y Li, W Zou, J Chen… - Drug Resistance …, 2023 - Elsevier
Abstract Development of resistance to chemotherapy in cancer continues to be a major
challenge in cancer management. Ferroptosis, a unique type of cell death, is mechanistically …

Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine …

S Zhao, L Wang, W Ding, B Ye, C Cheng… - Frontiers in …, 2023 - frontiersin.org
Background Bladder cancer (BLCA) is the most common malignancy of the urinary tract. On
the other hand, disulfidptosis, a mechanism of disulfide stress-induced cell death, is closely …

Diversity and complexity of cell death: a historical review

W Park, S Wei, BS Kim, B Kim, SJ Bae… - … & molecular medicine, 2023 - nature.com
Death is the inevitable fate of all living organisms, whether at the individual or cellular level.
For a long time, cell death was believed to be an undesirable but unavoidable final outcome …

miR-509–5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11

MA Elrebehy, TM Abdelghany, MM Elshafey… - … -Research and Practice, 2023 - Elsevier
Abstract Background/Aim Colorectal cancer (CRC), is characterized by aberrant microRNA
(miRNA) expression during their development and progression. Recently, miR-509–5p's …

[HTML][HTML] Emerging roles of cystathionine β-synthase in various forms of cancer

K Ascenção, C Szabo - Redox biology, 2022 - Elsevier
The expression of the reverse transsulfuration enzyme cystathionine-β-synthase (CBS) is
markedly increased in many forms of cancer, including colorectal, ovarian, lung, breast and …

Iron brain menace: the involvement of ferroptosis in Parkinson disease

KJ Lin, SD Chen, KL Lin, CW Liou, MY Lan… - Cells, 2022 - mdpi.com
Parkinson disease (PD) is the second-most common neurodegenerative disease. The
characteristic pathology of progressive dopaminergic neuronal loss in people with PD is …

Cellular modulators of the NRF2/KEAP1 signaling pathway in prostate cancer

G Tossetta, S Fantone, D Marzioni… - FRONTIERS IN …, 2023 - iris.univpm.it
Prostate cancer is the second most common malignancy in men worldwide. Prostate cancer
can be treated by surgery, radiotherapy and hormone therapy. The latter, in the form of …

AKT activation because of PTEN loss upregulates xCT via GSK3β/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells

KM Cahuzac, A Lubin, K Bosch, N Stokes… - Cell reports, 2023 - cell.com
Here, we show that the tumor suppressor phosphatase and tensin homolog deleted from
chromosome 10 (PTEN) sensitizes cells to ferroptosis, an iron-dependent form of cell death …

Hormesis and oxidative distress: Pathophysiology of reactive oxygen species and the open question of antioxidant modulation and supplementation

M Nitti, B Marengo, AL Furfaro, MA Pronzato… - Antioxidants, 2022 - mdpi.com
Alterations of redox homeostasis leads to a condition of resilience known as hormesis that is
due to the activation of redox-sensitive pathways stimulating cell proliferation, growth …